跳到主要内容

肯尼斯·I·凯廷的文章

健康2011年8月1日

新药匮乏

治疗神经精神疾病的药物对于大型制药公司而言风险过高

肯尼斯·I·凯廷, 克里斯托弗·P·米尔恩

Expand Your World with Science

Learn and share the most exciting discoveries, innovations and ideas shaping our world today.

Subscribe Sign up for our newsletters See the latest stories Read the latest issue Give a Gift Subscription

Follow Us:

Return & Refund Policy
About
Press Room

FAQs
Contact Us
International Editions

Advertise
Accessibility Statement
Terms of Use

Privacy Policy
California Consumer Privacy Statement
Use of cookies/Do not sell my data

大众科学 is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www.springernature.com/us). 大众科学 maintains a strict policy of editorial independence in reporting developments in science to our readers.

© 2024 大众科学, A DIVISION OF SPRINGER NATURE AMERICA, INC.
ALL RIGHTS RESERVED.

© .